Gastroenterology

Journal

Publication Venue For

  • NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12..  155:880-891.e8. 2018
  • Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response..  155:33-37.e6. 2018
  • Just the FRAX: Management of Glucocorticoid-Induced Osteoporosis..  154:748-750. 2018
  • A Rare Cause of Recurrent Abdominal Pain and Diarrhea..  155:e11-e12. 2018
  • Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease..  153:1260-1272.e3. 2017
  • Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass..  152:1055-1067.e3. 2017
  • Infection in Severe Alcoholic Hepatitis: Yet Another Piece in the Puzzle..  152:938-940. 2017
  • Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis..  152:911-912. 2017
  • Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease..  152:206-217.e2. 2016
  • Abdominal Pain With an Unusual Radiographic Image..  151:241-242. 2016
  • Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1..  150:1579-1589.e2. 2016
  • Elucidating the Role of the Interleukin-10 Receptor in Mucosal Inflammation Uncovers a Potential Treatment for Infantile Inflammatory Bowel Disease..  151:1061-1062. 2016
  • Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells..  149:1825-1836.e5. 2015
  • Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans..  149:1575-1586. 2015
  • Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis..  149:958-70.e12. 2015
  • A rare case of chronic diarrhea..  148:510-512. 2015
  • A new meaning to butterflies in the stomach..  148:e12-e13. 2015
  • Administration of secretin (RG1068) increases the sensitivity of detection of duct abnormalities by magnetic resonance cholangiopancreatography in patients with pancreatitis..  147:646-654.e2. 2014
  • An unusual familial, recurrent neoplasm..  146:e11-e12. 2014
  • Su1992 TNF Mediates β-Catenin Activation in Intestinal Stem Cells During Colitis.  146:S-516-S-516. 2014
  • Ca2+ responses in enteric glia are mediated by connexin-43 hemichannels and modulate colonic transit in mice..  146:497-507.e1. 2014
  • MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy..  146:188-199. 2014
  • Reply: To PMID 23732774..  146:320. 2014
  • Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate..  145:1334-46.e1-11. 2013
  • Equal efficacy of endoscopic and surgical cystogastrostomy for pancreatic pseudocyst drainage in a randomized trial..  145:583-90.e1. 2013
  • Second opinion..  145:61-261. 2013
  • A most unusual passage per rectum..  144:e3-e4. 2013
  • How to value technological innovation: a proposal for determining relative clinical value..  144:5-8. 2013
  • Endoscopic therapy for sphincter of Oddi dysfunction in idiopathic pancreatitis: from empiric to scientific..  143:1423-1426. 2012
  • Hepatitis C virus infects the endothelial cells of the blood-brain barrier..  142:634-643.e6. 2012
  • Stromal regulation of human gastric dendritic cells restricts the Th1 response to Helicobacter pylori..  141:929-938. 2011
  • Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis..  140:2031-2043. 2011
  • Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents..  140:1586-96.e6. 2011
  • Environmental triggers, genetic background, and Crohn's disease..  140:363-365. 2011
  • IL-12 converts Foxp3(+) regulatory T cells to Foxp3(+)IFN-γ(+) T cells with inhibitory functions during induction of colitis.  140:2031-43. 2011
  • TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine..  140:242-253. 2011
  • Abdominal pain in a young man with severe hypertension..  139:733-1067. 2010
  • Phosphoinositide 3-Kinase Signaling Mediates β-Catenin Activation in Intestinal Epithelial Stem and Progenitor Cells in Colitis.  139:869-881.e9. 2010
  • Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways..  139:598-608. 2010
  • Laparoscopy improves short-term outcomes after surgery for diverticular disease..  138:2267-2274.e1. 2010
  • Antimetastatic role of Smad4 signaling in colorectal cancer..  138:969-80.e1-3. 2010
  • Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer..  138:958-968. 2010
  • Mesalamine Inhibits Epithelial β-Catenin Activation in Chronic Ulcerative Colitis.  138:595-605.e3. 2010
  • State of research in pediatric gastroenterology, hepatology, and nutrition: 2010 and beyond..  138:411-416.e2. 2010
  • Endoscopist-directed administration of propofol: a worldwide safety experience..  137:1229-1237. 2009
  • Fecal incontinence in US adults: epidemiology and risk factors..  137:512-517.e2. 2009
  • Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms..  136:1772-1782. 2009
  • Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome..  136:1070-1080. 2009
  • High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay..  136:459-470. 2009
  • Gut Permeability and Colitis.  137:732-734. 2009
  • A common barrier defect for celiac disease and ulcerative colitis..  135:2145-2147. 2008
  • Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates..  135:1168-1175. 2008
  • Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells..  135:917-925. 2008
  • Evaluation and management of end-stage liver disease in children..  134:1741-1751. 2008
  • Helicobacter pylori gastritis in children is associated with a regulatory T-cell response..  134:491-499. 2008
  • Response to Ray and colleagues: the called-for large clinical trial is already ongoing..  134:370-371. 2008
  • The genetics of inflammatory bowel disease..  133:1327-1339. 2007
  • Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice..  133:108-123. 2007
  • Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice..  132:2359-2370. 2007
  • Reply.  132:2608-2609. 2007
  • State of pediatric gastroenterology, hepatology, and nutrition: 2006 and beyond..  132:434-436. 2007
  • A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis..  131:1381-1391. 2006
  • Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency..  131:748-756. 2006
  • Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota..  130:2050-2059. 2006
  • Psychosocial aspects of the functional gastrointestinal disorders..  130:1447-1458. 2006
  • Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens..  129:1473-1484. 2005
  • Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome..  129:682-695. 2005
  • Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease..  128:2020-2028. 2005
  • Presentation of the Julius M. Friedenwald Medal to Ralph A. Giannella, MD..  128:2152-2157. 2005
  • National Institutes of Health Consensus Development Conference Statement on Celiac Disease, June 28-30, 2004..  128:S1-S9. 2005
  • Behavioral treatment options for urinary incontinence..  126:S82-S89. 2004
  • Predictors of treatment response to behavioral therapy and pharmacotherapy for urinary incontinence..  126:S141-S145. 2004
  • Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome..  125:1441-1451. 2003
  • Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer..  125:1203-1218. 2003
  • Cholera toxin adjuvanticity is dependent upon Gm1-mediated NF-κB translocation and activation of dendritic cells.  124:A73-A73. 2003
  • T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice..  124:672-682. 2003
  • Novel genes and functional relationships in the adult mouse gastrointestinal tract identified by microarray analysis..  122:1467-1482. 2002
  • An antigen specific colitis model: TNBS (trinitrobenzene sulfonic acid) colitis without EtOH using adoptive T cell transfer.  122:A392-A392. 2002
  • Small intestinal transformation and wasting disease induced in T cell deficient mice by adoptive transfer of CD45RB(Hi) Th2 cells.  122:A73-A73. 2002
  • Increases in guanylin and uroguanylin in a mouse model of osmotic diarrhea are guanylate cyclase C-independent..  121:1191-1202. 2001
  • A revisit of the hapten-induced colitis model: Adoptive T cell transfer studies..  120:A193-A193. 2001
  • The value of splenic preservation with distal pancreatectomy.  120:A485-A485. 2001
  • The value of splenic preservation with distal pancreatectomy.  120:A485-A485. 2001
  • Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management..  120:607-621. 2001
  • Emerging concepts in the pathophysiology and management of the gastrointestinal manifestations of AIDS.  120:607-21. 2001
  • Identification of a new chloride channel: a sweet story?.  120:299-303. 2001
  • Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group..  119:1473-1482. 2000
  • Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis..  119:724-733. 2000
  • Commensal bacteria as targets in Crohn's disease..  119:254-257. 2000
  • The requirement for lymphotoxin and Peyer's patches in the development of intestinal lamina propria lymphocytes.  118:A361-A361. 2000
  • American Gastroenterological Association medical position statement: evaluation and management of occult and obscure gastrointestinal bleeding..  118:197-201. 2000
  • Kappa opioid receptor agonists differentially inhibit two classes of rat spinal neurons excited by colorectal distention..  117:388-394. 1999
  • Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5..  116:1043-1053. 1999
  • Our new president-ralph A. Giannella, M.D.  116:1238-1243. 1999
  • Gastroenterology fellowship training: a generation lost..  116:228. 1999
  • Intraepithelial lymphocytes from villus tip and crypt portions of the murine small intestine show distinct characteristics..  115:866-873. 1998
  • Regional differences in L-selectin expression in murine intestinal lymphocytes..  114:965-974. 1998
  • Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach..  114:305-310. 1998
  • High mucosal levels of tumor necrosis factor alpha messenger RNA in AIDS-associated cytomegalovirus-induced esophagitis..  114:77-82. 1998
  • Cost of endoscopy in economic evaluation..  113:2023-2024. 1997
  • A prognostic model for patients with end-stage liver disease..  113:1278-1288. 1997
  • Uroguanylin and guanylin: distinct but overlapping patterns of messenger RNA expression in mouse intestine..  113:1000-1006. 1997
  • Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group..  113:383-389. 1997
  • Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis..  112:1078-1086. 1997
  • AGA technical review: malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection..  111:1724-1752. 1996
  • Endoscopic therapy for organized pancreatic necrosis..  111:755-764. 1996
  • Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production..  111:419-425. 1996
  • Chronic unexplained diarrhea in human immunodeficiency virus infection: determination of the best diagnostic approach..  111:269-271. 1996
  • Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms..  110:1803-1809. 1996
  • Passing the torch: a look back at our editorship..  110:1336-1338. 1996
  • Factor analysis of gastrointestinal symptoms..  110:969-970. 1996
  • Chronic unexplained diarrhea in human immunodeficiency virus infection: determination of the best diagnostic approach..  110:30-37. 1996
  • Wherefore art thou guanylin?.  109:2039-2042. 1995
  • Experimental models of inflammatory bowel disease..  109:1344-1367. 1995
  • Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea..  108:1753-1760. 1995
  • Sexual abuse and gastrointestinal disease..  108:1945-1946. 1995
  • Coping with irritable bowel syndrome IBS): Analgesic and other medication use by IBS patients and IBS non-consulter.  108:A577-A577. 1995
  • Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice..  107:1643-1652. 1994
  • Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice..  107:1726-1735. 1994
  • Relaxation training reduces symptom reports and acid exposure in patients with gastroesophageal reflux disease..  107:61-69. 1994
  • FACTOR-ANALYSIS OF GI SYMPTOMS SUPPORTS ROME CRITERIA FOR FUNCTIONAL GI DISORDERS.  106:A589-A589. 1994
  • Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis..  106:907-915. 1994
  • TNBS-SPECIFIC ORAL TOLERANCE PROTECTS FROM HAPTEN-INDUCED COLITIS.  106:A772-A772. 1994
  • Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells..  105:1857-1864. 1993
  • CYTOKINE SECRETION BY INTRAEPITHELIAL (IEL) AND LAMINA PROPRIA LYMPHOCYTES (LPL) FROM MURINE SMALL-BOWEL (SB) AND LARGE-BOWEL (LB).  104:A780-A780. 1993
  • EMOTIONAL DISTRESS, RELAXATION AND AIR SWALLOWING RATE - A POSSIBLE ETIOLOGIC MECHANISM IN SOME GASTROINTESTINAL DISORDERS.  104:A1035-A1035. 1993
  • FACTOR-ANALYSIS OF BOWEL SYMPTOMS - REPLICATION IN 2045 STUDENTS.  104:A492-A492. 1993
  • Ischemia/reperfusion-induced feline intestinal dysfunction: importance of granulocyte recruitment..  103:807-812. 1992
  • Pyostomatitis vegetans and primary sclerosing cholangitis: markers of inflammatory bowel disease..  103:668-674. 1992
  • Jejunal toxin inactivation regulates susceptibility of the immature rat to STa..  102:1988-1996. 1992
  • Mesenteric vasoconstriction in cardiogenic shock in pigs..  102:1968-1979. 1992
  • Escherichia coli enterotoxin (STa) binds to receptors, stimulates guanyl cyclase, and impairs absorption in rat colon..  102:816-822. 1992
  • Complications of percutaneous liver biopsy in children..  102:629-632. 1992
  • Endoscopy-negative upper gastrointestinal bleeding in a patient with chronic pancreatitis..  102:320-329. 1992
  • Interleukin-10 and counting.....  100:1778. 1991
  • Adenovirus colitis in the acquired immunodeficiency syndrome..  100:976-979. 1991
  • High-protein ascites in patients with the acquired immunodeficiency syndrome..  100:745-748. 1991
  • Cytomegalovirus-associated acute pancreatic disease in patients with acquired immunodeficiency syndrome. Report of two patients..  99:263-267. 1990
  • Cyclosporine in Crohn's Disease-- Low Doses Won't Do It. Selected Summary.  98:1383-4. 1990
  • Cytokines can make you sick - or keep you well. Selected Summary..  98:536-8. 1990
  • Cytokines can make you sick-Or keep you well.  98:1095-1096. 1990
  • Do organ-specific suppressor T cells prevent autoimmune gastritis?.  98:226-229. 1990
  • Liver biopsy in the long-term follow-up of liver transplant patients: Still the gold standard (I: Reply).  99:1183. 1990
  • Primary Biliary Cirrhosis in a Mouse? Selected Summary.  99:1181-3. 1990
  • Reply.  98:1726-1727. 1990
  • Liver transplantation in a patient with protoporphyria..  97:188-194. 1989
  • Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease..  96:764-768. 1989
  • Specialized receptors for antigens on gut epithelial T cells. Selected Summary.  97:1341-2. 1989
  • Hepatic and bile porphyrins in patients with protoporphyria and liver failure..  94:1488-1492. 1988
  • Receptor-mediated binding and uptake of immunoglobulin A by human liver..  94:762-770. 1988
  • Age-related differences in receptors for Escherichia coli heat-stable enterotoxin in the small and large intestine of children..  94:367-373. 1988
  • Collagen content and types in the intestinal strictures of Crohn's disease..  94:257-265. 1988
  • Collagen content and types in normal intestine and in the strictures of Crohn's disease.  94:251-65. 1988
  • Expression of human immunoglobulin G subclasses in inflammatory bowel disease..  93:1127-1129. 1987
  • Progressive bile duct injury after thiabendazole administration..  93:245-249. 1987
  • Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus..  93:21-28. 1987
  • Collagen synthesis by human intestinal smooth muscle cells in culture..  92:400-405. 1987
  • Intestinal immunity and inflammation: recent progress..  91:746-768. 1986
  • Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation..  90:2004-2007. 1986
  • Role of oxygen radicals in ischemia-induced lesions in the cat stomach..  90:362-367. 1986
  • Xanthine oxidase inhibitors attenuate ischemia-induced vascular permeability changes in the cat intestine..  90:80-84. 1986
  • Relationship of blood flow and oxygen consumption to ischemic injury in the canine small intestine..  89:852-857. 1985
  • T cell-B cell regulation in the intestinal lamina propria in Crohn's disease..  89:321-327. 1985
  • Human pancreatic acinar cells: studies of stimulus-secretion coupling..  89:109-117. 1985
  • Soybean trypsin inhibitor attenuates ischemic injury to the feline small intestine..  89:6-12. 1985
  • Hypogammaglobulinemia due to abnormal suppressor T-cell activity in Crohn's disease..  86:569-576. 1984
  • Enzymatic formation of zinc-protoporphyrin by rat liver and its potential effect on hepatic heme metabolism..  85:663-668. 1983
  • Infectious agents and inflammatory bowel disease..  85:475-476. 1983
  • Use of diuretics in the treatment of cirrhotic ascites.  84:1051-1055. 1983
  • Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response..  83:797-803. 1982
  • Treatment of carbon tetrachloride poisoning with hyperbaric oxygen..  82:767-769. 1982
  • Evidence that hepatic crystalline deposits in a patient with protoporphyria are composed of protoporphyrin..  82:569-573. 1982
  • Properties of immunoglobulin A in serum of individuals with liver diseases and in hepatic bile..  82:184-193. 1982
  • Ischemic injury in the cat small intestine: role of superoxide radicals..  82:9-15. 1982
  • Streptozotocin-induced diabetes stimulates bile salt sulfation in male rats.  82:1013. 1982
  • Covert suppressor T cells in Crohn's disease..  80:1513-1521. 1981
  • IgG antibody to Giardia lamblia detected by enzyme-linked immunosorbent assay..  80:1476-1480. 1981
  • Cholesterol feeding does not alter the defective chylomicron remnant (CMR) uptake by Morris hepatoma.  80:1131. 1981
  • Chronic proctitis in male homosexuals due to lymphogranuloma venereum..  79:563-565. 1980
  • Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis..  79:242-254. 1980
  • Effect of hematin administration to patients with protoporphyria and liver disease.  79:1100. 1980
  • Utilization of a radioiodinated bile salt for kinetic studies and hepatic scintigraphy. Studies in nonhuman mammals..  76:272-278. 1979
  • Physical Chemical and Technical Limitations to Intragastric Titration.  76:1025-1034. 1979
  • Bile acids in portal blood..  74:964-965. 1978
  • Serum disappearance of cholylglycine (CG).  74:1006. 1978
  • Effect of acetylsalicylic acid on the amphibian gastric mucosa. I. Electrophysiological and permeability changes.  73:785-789. 1977
  • Effect of acetylsalicylic acid on gastric mucosa. II. Mucosal ATP and phosphocreatine content, and salicylate effects on mitochondrial metabolism..  73:995-999. 1977
  • Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus..  73:1125-1130. 1977
  • Small intestinal injury in the graft versus host reaction: an innocent bystander phenomenon..  72:886-889. 1977
  • Serum alpha-fetoprotein in patients with massive hepatic necrosis..  72:479-492. 1977
  • Acetylsalicylate hydrolase (esterase) of fundic gastric mucosa.  72. 1977
  • An125I Radioimmunoassay for Primary Conjugated Bile Salts.  72:305-311. 1977
  • Liver failure with alcoholic like hyaline after jejuno ileal bypass; reversal by parenteral nutrition and reanastomosis.  72. 1977
  • Properties of gastric antrum. III. Selectivity and modification of shunt conductance..  72:72-77. 1977
  • The effect of acetylation (AC) status on cholestasis and hepatocellular damage (HCD) in isoniazid (INH) induced liver disease.  72. 1977
  • The hepatic porphyrias: pathogenesis, manifestations, and management..  71:689-701. 1976
  • Reversal of growth arrest in adolescents with Crohn's disease after parenteral alimentation..  70:1017-1021. 1976
  • A primary conjugated bile salt radioimmunoassay using an iodinated bile salt derivative.  70:940. 1976
  • Effect of drug withdrawal on hepatic abnormalities in parenteral narcotic addicts.  70:987. 1976
  • Radioiodinated cholylglycylhistamine: a potentially useful, physiologic hepatic scanning agent.  70:940. 1976
  • Polymicrobial sepsis following endoscopic retrograde cholangiopancreatography..  69:507-510. 1975
  • Relationship of serum alpha-fetoprotein to the severity and duration of illness in patients with viral hepatitis..  68:342-350. 1975
  • Birefringence of hepatic pigment deposits in erythropoietic protoporphyria. Specificity of polarization microscopy in the identification of hepatic protoporphyrin deposits..  67:294-302. 1974
  • Inhibition of bilirubin excretion in man during dehydrocholate choleresis..  65:929-935. 1973
  • Studies on the mechanism of fasting hyperbilirubinemia..  61:479-487. 1971
  • International Standard Serial Number (issn)

  • 0016-5085
  • Electronic International Standard Serial Number (eissn)

  • 1528-0012